Table of Content

1 Market Overview of Viral Gene Therapy
1.1 Viral Gene Therapy Market Overview
1.1.1 Viral Gene Therapy Product Scope
1.1.2 Viral Gene Therapy Market Status and Outlook
1.2 Global Viral Gene Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Viral Gene Therapy Market Size by Region (2018-2029)
1.4 Global Viral Gene Therapy Historic Market Size by Region (2018-2024)
1.5 Global Viral Gene Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Viral Gene Therapy Market Size (2018-2029)
1.6.1 North America Viral Gene Therapy Market Size (2018-2029)
1.6.2 Europe Viral Gene Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Viral Gene Therapy Market Size (2018-2029)
1.6.4 Latin America Viral Gene Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Viral Gene Therapy Market Size (2018-2029)
2 Viral Gene Therapy Market by Type
2.1 Introduction
2.1.1 Integrating Viral Vectors
2.1.2 Non-Integrating Viral Vectors
2.2 Global Viral Gene Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Viral Gene Therapy Historic Market Size by Type (2018-2024)
2.2.2 Global Viral Gene Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Viral Gene Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Viral Gene Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Viral Gene Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Viral Gene Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Viral Gene Therapy Revenue Breakdown by Type (2018-2029)
3 Viral Gene Therapy Market Overview by Application
3.1 Introduction
3.1.1 Metabolic Diseases
3.1.2 Cardiovascular Diseases
3.1.3 Muscular Diseases
3.1.4 Hematologic Diseases
3.1.5 Ophthalmologic Diseases
3.1.6 Infectious Diseases
3.1.7 Others
3.2 Global Viral Gene Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Viral Gene Therapy Historic Market Size by Application (2018-2024)
3.2.2 Global Viral Gene Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Viral Gene Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Viral Gene Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Viral Gene Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Viral Gene Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Viral Gene Therapy Revenue Breakdown by Application (2018-2029)
4 Viral Gene Therapy Competition Analysis by Players
4.1 Global Viral Gene Therapy Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Gene Therapy as of 2022)
4.3 Date of Key Players Enter into Viral Gene Therapy Market
4.4 Global Top Players Viral Gene Therapy Headquarters and Area Served
4.5 Key Players Viral Gene Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Viral Gene Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Lonza
5.1.1 Lonza Profile
5.1.2 Lonza Main Business
5.1.3 Lonza Viral Gene Therapy Products, Services and Solutions
5.1.4 Lonza Viral Gene Therapy Revenue (US$ Million) & (2018-2024)
5.1.5 Lonza Recent Developments
5.2 Biogen
5.2.1 Biogen Profile
5.2.2 Biogen Main Business
5.2.3 Biogen Viral Gene Therapy Products, Services and Solutions
5.2.4 Biogen Viral Gene Therapy Revenue (US$ Million) & (2018-2024)
5.2.5 Biogen Recent Developments
5.3 Catalent
5.3.1 Catalent Profile
5.3.2 Catalent Main Business
5.3.3 Catalent Viral Gene Therapy Products, Services and Solutions
5.3.4 Catalent Viral Gene Therapy Revenue (US$ Million) & (2018-2024)
5.3.5 Gilead Sciences Recent Developments
5.4 Gilead Sciences
5.4.1 Gilead Sciences Profile
5.4.2 Gilead Sciences Main Business
5.4.3 Gilead Sciences Viral Gene Therapy Products, Services and Solutions
5.4.4 Gilead Sciences Viral Gene Therapy Revenue (US$ Million) & (2018-2024)
5.4.5 Gilead Sciences Recent Developments
5.5 Sarepta Therapeutics
5.5.1 Sarepta Therapeutics Profile
5.5.2 Sarepta Therapeutics Main Business
5.5.3 Sarepta Therapeutics Viral Gene Therapy Products, Services and Solutions
5.5.4 Sarepta Therapeutics Viral Gene Therapy Revenue (US$ Million) & (2018-2024)
5.5.5 Sarepta Therapeutics Recent Developments
5.6 Novartis
5.6.1 Novartis Profile
5.6.2 Novartis Main Business
5.6.3 Novartis Viral Gene Therapy Products, Services and Solutions
5.6.4 Novartis Viral Gene Therapy Revenue (US$ Million) & (2018-2024)
5.6.5 Novartis Recent Developments
5.7 Amgen
5.7.1 Amgen Profile
5.7.2 Amgen Main Business
5.7.3 Amgen Viral Gene Therapy Products, Services and Solutions
5.7.4 Amgen Viral Gene Therapy Revenue (US$ Million) & (2018-2024)
5.7.5 Amgen Recent Developments
5.8 Ionis Pharmaceuticals
5.8.1 Ionis Pharmaceuticals Profile
5.8.2 Ionis Pharmaceuticals Main Business
5.8.3 Ionis Pharmaceuticals Viral Gene Therapy Products, Services and Solutions
5.8.4 Ionis Pharmaceuticals Viral Gene Therapy Revenue (US$ Million) & (2018-2024)
5.8.5 Ionis Pharmaceuticals Recent Developments
5.9 Spark Therapeutics
5.9.1 Spark Therapeutics Profile
5.9.2 Spark Therapeutics Main Business
5.9.3 Spark Therapeutics Viral Gene Therapy Products, Services and Solutions
5.9.4 Spark Therapeutics Viral Gene Therapy Revenue (US$ Million) & (2018-2024)
5.9.5 Spark Therapeutics Recent Developments
5.10 Shanghai Sunway Biotech
5.10.1 Shanghai Sunway Biotech Profile
5.10.2 Shanghai Sunway Biotech Main Business
5.10.3 Shanghai Sunway Biotech Viral Gene Therapy Products, Services and Solutions
5.10.4 Shanghai Sunway Biotech Viral Gene Therapy Revenue (US$ Million) & (2018-2024)
5.10.5 Shanghai Sunway Biotech Recent Developments
5.11 SIBIONO
5.11.1 SIBIONO Profile
5.11.2 SIBIONO Main Business
5.11.3 SIBIONO Viral Gene Therapy Products, Services and Solutions
5.11.4 SIBIONO Viral Gene Therapy Revenue (US$ Million) & (2018-2024)
5.11.5 SIBIONO Recent Developments
5.12 AnGes
5.12.1 AnGes Profile
5.12.2 AnGes Main Business
5.12.3 AnGes Viral Gene Therapy Products, Services and Solutions
5.12.4 AnGes Viral Gene Therapy Revenue (US$ Million) & (2018-2024)
5.12.5 AnGes Recent Developments
5.13 Orchard Therapeutics
5.13.1 Orchard Therapeutics Profile
5.13.2 Orchard Therapeutics Main Business
5.13.3 Orchard Therapeutics Viral Gene Therapy Products, Services and Solutions
5.13.4 Orchard Therapeutics Viral Gene Therapy Revenue (US$ Million) & (2018-2024)
5.13.5 Orchard Therapeutics Recent Developments
6 North America
6.1 North America Viral Gene Therapy Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Viral Gene Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Viral Gene Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Viral Gene Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Viral Gene Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Viral Gene Therapy Market Dynamics
11.1 Viral Gene Therapy Industry Trends
11.2 Viral Gene Therapy Market Drivers
11.3 Viral Gene Therapy Market Challenges
11.4 Viral Gene Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Viral Gene Therapy Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Viral Gene Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Viral Gene Therapy Market Size Share by Region (2018-2024)
Table 4. Global Viral Gene Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Viral Gene Therapy Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Viral Gene Therapy Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Viral Gene Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Viral Gene Therapy Revenue Market Share by Type (2018-2024)
Table 9. Global Viral Gene Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Viral Gene Therapy Revenue Market Share by Type (2024-2029)
Table 11. North America Viral Gene Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Viral Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Viral Gene Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Viral Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Viral Gene Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Viral Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Viral Gene Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Viral Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Viral Gene Therapy Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Viral Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Viral Gene Therapy Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Viral Gene Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Viral Gene Therapy Revenue Market Share by Application (2018-2024)
Table 24. Global Viral Gene Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Viral Gene Therapy Revenue Market Share by Application (2024-2029)
Table 26. North America Viral Gene Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Viral Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Viral Gene Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Viral Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Viral Gene Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Viral Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Viral Gene Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Viral Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Viral Gene Therapy Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Viral Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Viral Gene Therapy Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Viral Gene Therapy Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Viral Gene Therapy as of 2022)
Table 39. Date of Key Players Enter into Viral Gene Therapy Market
Table 40. Global Viral Gene Therapy Key Players Headquarters and Area Served
Table 41. Viral Gene Therapy Product Solution and Service
Table 42. Global Viral Gene Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Lonza Basic Information List
Table 45. Lonza Description and Business Overview
Table 46. Lonza Viral Gene Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in Viral Gene Therapy Business of Lonza (2018-2024)
Table 48. Lonza Recent Developments
Table 49. Biogen Basic Information List
Table 50. Biogen Description and Business Overview
Table 51. Biogen Viral Gene Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in Viral Gene Therapy Business of Biogen (2018-2024)
Table 53. Biogen Recent Developments
Table 54. Catalent Basic Information List
Table 55. Catalent Description and Business Overview
Table 56. Catalent Viral Gene Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in Viral Gene Therapy Business of Catalent (2018-2024)
Table 58. Catalent Recent Developments
Table 59. Gilead Sciences Basic Information List
Table 60. Gilead Sciences Description and Business Overview
Table 61. Gilead Sciences Viral Gene Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in Viral Gene Therapy Business of Gilead Sciences (2018-2024)
Table 63. Gilead Sciences Recent Developments
Table 64. Sarepta Therapeutics Basic Information List
Table 65. Sarepta Therapeutics Description and Business Overview
Table 66. Sarepta Therapeutics Viral Gene Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in Viral Gene Therapy Business of Sarepta Therapeutics (2018-2024)
Table 68. Sarepta Therapeutics Recent Developments
Table 69. Novartis Basic Information List
Table 70. Novartis Description and Business Overview
Table 71. Novartis Viral Gene Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in Viral Gene Therapy Business of Novartis (2018-2024)
Table 73. Novartis Recent Developments
Table 74. Amgen Basic Information List
Table 75. Amgen Description and Business Overview
Table 76. Amgen Viral Gene Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in Viral Gene Therapy Business of Amgen (2018-2024)
Table 78. Amgen Recent Developments
Table 79. Ionis Pharmaceuticals Basic Information List
Table 80. Ionis Pharmaceuticals Description and Business Overview
Table 81. Ionis Pharmaceuticals Viral Gene Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in Viral Gene Therapy Business of Ionis Pharmaceuticals (2018-2024)
Table 83. Ionis Pharmaceuticals Recent Developments
Table 84. Spark Therapeutics Basic Information List
Table 85. Spark Therapeutics Description and Business Overview
Table 86. Spark Therapeutics Viral Gene Therapy Products, Services and Solutions
Table 87. Revenue (US$ Million) in Viral Gene Therapy Business of Spark Therapeutics (2018-2024)
Table 88. Spark Therapeutics Recent Developments
Table 89. Shanghai Sunway Biotech Basic Information List
Table 90. Shanghai Sunway Biotech Description and Business Overview
Table 91. Shanghai Sunway Biotech Viral Gene Therapy Products, Services and Solutions
Table 92. Revenue (US$ Million) in Viral Gene Therapy Business of Shanghai Sunway Biotech (2018-2024)
Table 93. Shanghai Sunway Biotech Recent Developments
Table 94. SIBIONO Basic Information List
Table 95. SIBIONO Description and Business Overview
Table 96. SIBIONO Viral Gene Therapy Products, Services and Solutions
Table 97. Revenue (US$ Million) in Viral Gene Therapy Business of SIBIONO (2018-2024)
Table 98. SIBIONO Recent Developments
Table 99. AnGes Basic Information List
Table 100. AnGes Description and Business Overview
Table 101. AnGes Viral Gene Therapy Products, Services and Solutions
Table 102. Revenue (US$ Million) in Viral Gene Therapy Business of AnGes (2018-2024)
Table 103. AnGes Recent Developments
Table 104. Orchard Therapeutics Basic Information List
Table 105. Orchard Therapeutics Description and Business Overview
Table 106. Orchard Therapeutics Viral Gene Therapy Products, Services and Solutions
Table 107. Revenue (US$ Million) in Viral Gene Therapy Business of Orchard Therapeutics (2018-2024)
Table 108. Orchard Therapeutics Recent Developments
Table 109. North America Viral Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 110. North America Viral Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 111. Europe Viral Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 112. Europe Viral Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 113. Asia-Pacific Viral Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 114. Asia-Pacific Viral Gene Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 115. Asia-Pacific Viral Gene Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 116. Asia-Pacific Viral Gene Therapy Market Share by Region (2018-2024)
Table 117. Asia-Pacific Viral Gene Therapy Market Share by Region (2024-2029)
Table 118. Latin America Viral Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 119. Latin America Viral Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 120. Latin America Viral Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 121. Middle East & Africa Viral Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 122. Middle East & Africa Viral Gene Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 123. Middle East & Africa Viral Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 124. Viral Gene Therapy Market Trends
Table 125. Viral Gene Therapy Market Drivers
Table 126. Viral Gene Therapy Market Challenges
Table 127. Viral Gene Therapy Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Gene Therapy Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Viral Gene Therapy Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Viral Gene Therapy Market Share by Regions: 2022 VS 2029
Figure 4. Global Viral Gene Therapy Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Viral Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Viral Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Viral Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Viral Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Viral Gene Therapy Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of Integrating Viral Vectors
Figure 11. Global Integrating Viral Vectors Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of Non-Integrating Viral Vectors
Figure 13. Global Non-Integrating Viral Vectors Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Viral Gene Therapy Market Size Share by Type: 2022 & 2029
Figure 15. North America Viral Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 16. Europe Viral Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Viral Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Viral Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Viral Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 20. Metabolic Diseases Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Cardiovascular Diseases Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Muscular Diseases Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 23. Hematologic Diseases Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 24. Ophthalmologic Diseases Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 25. Infectious Diseases Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 26. Others Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 27. Global Viral Gene Therapy Market Size Share by Application: 2022 & 2029
Figure 28. North America Viral Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 29. Europe Viral Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 30. Asia-Pacific Viral Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 31. Latin America Viral Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 32. Middle East and Africa Viral Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 33. Viral Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 34. Global Top 5 and Top 10 Players Viral Gene Therapy Market Share in 2022
Figure 35. North America Viral Gene Therapy Market Share by Country (2018-2029)
Figure 36. United States Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 37. Canada Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 38. Germany Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 39. France Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 40. U.K. Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 41. Italy Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 42. Russia Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 43. Nordic Countries Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 44. Asia-Pacific Viral Gene Therapy Market Share by Region (2018-2029)
Figure 45. China Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 46. Japan Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 47. South Korea Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 48. Southeast Asia Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 49. India Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 50. Australia Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 51. Latin America Viral Gene Therapy Market Share by Country (2018-2029)
Figure 52. Mexico Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 53. Brazil Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 54. Middle East & Africa Viral Gene Therapy Market Share by Country (2018-2029)
Figure 55. Turkey Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 57. UAE Viral Gene Therapy Market Size (2018-2029) & (US$ Million)
Figure 58. Bottom-up and Top-down Approaches for This Report